Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 104

1.

What can SV40-derived vectors do for gene therapy?

Strayer DS, Zern MA, Chowdhury JR.

Curr Opin Mol Ther. 2002 Aug;4(4):313-23. Review.

PMID:
12222869
2.

Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors.

Strayer D, Branco F, Zern MA, Yam P, Calarota SA, Nichols CN, Zaia JA, Rossi J, Li H, Parashar B, Ghosh S, Chowdhury JR.

Mol Ther. 2002 Aug;6(2):227-37.

3.

Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection.

Guha C, Parashar B, Deb NJ, Garg M, Gorla GR, Singh A, Roy-Chowdhury N, Vikram B, Roy-Chowdhury J.

Hepatology. 2002 Aug;36(2):354-62.

PMID:
12143043
5.

siRNA-directed inhibition of HIV-1 infection.

Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P, Sharp PA.

Nat Med. 2002 Jul;8(7):681-6. Epub 2002 Jun 3.

PMID:
12042777
6.

Evolution of adenoviruses as gene therapy vectors.

Roy-Chowdhury J, Horwitz MS.

Mol Ther. 2002 Apr;5(4):340-4. No abstract available.

7.

A system for stable expression of short interfering RNAs in mammalian cells.

Brummelkamp TR, Bernards R, Agami R.

Science. 2002 Apr 19;296(5567):550-3. Epub 2002 Mar 21.

8.

Oligonucleotide-mediated site-directed gene repair.

Kren BT, Bandyopadhyay P, Chowdhury NR, Chowdhury JR, Steer CJ.

Methods Enzymol. 2002;346:14-35. No abstract available.

PMID:
11883065
9.

A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency.

Raper SE, Yudkoff M, Chirmule N, Gao GP, Nunes F, Haskal ZJ, Furth EE, Propert KJ, Robinson MB, Magosin S, Simoes H, Speicher L, Hughes J, Tazelaar J, Wivel NA, Wilson JM, Batshaw ML.

Hum Gene Ther. 2002 Jan 1;13(1):163-75.

PMID:
11779420
10.

Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.

Einfeld DA, Schroeder R, Roelvink PW, Lizonova A, King CR, Kovesdi I, Wickham TJ.

J Virol. 2001 Dec;75(23):11284-91.

11.

A selection system for identifying accessible sites in target RNAs.

Pan WH, Devlin HF, Kelley C, Isom HC, Clawson GA.

RNA. 2001 Apr;7(4):610-21.

12.

Engraftment and albumin production of intrasplenically transplanted rat hepatocytes (Sprague-Dawley), freshly isolated versus cryopreserved, into Nagase analbuminemic rats (NAR).

David P, Alexandre E, Audet M, Chenard-Neu MP, Wolf P, Jaeck D, Azimzadeh A, Richert L.

Cell Transplant. 2001 Jan-Feb;10(1):67-80.

PMID:
11294474
13.

Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty.

Tagalakis AD, Graham IR, Riddell DR, Dickson JG, Owen JS.

J Biol Chem. 2001 Apr 20;276(16):13226-30. Epub 2001 Feb 13.

14.

Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle.

Song S, Laipis PJ, Berns KI, Flotte TR.

Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4084-8. Epub 2001 Mar 13.

15.

Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease.

Irani AN, Malhi H, Slehria S, Gorla GR, Volenberg I, Schilsky ML, Gupta S.

Mol Ther. 2001 Mar;3(3):302-9.

16.

Prospects for xenotransplantation of the liver.

Kanazawa A, Platt JL.

Semin Liver Dis. 2000;20(4):511-22. Review.

PMID:
11200419
17.

Liver irradiation: a potential preparative regimen for hepatocyte transplantation.

Guha C, Parashar B, Deb NJ, Sharma A, Gorla GR, Alfieri A, Roy-Chowdhury N, Roy-Chowdhury J, Vikram B.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):451-7. Review.

PMID:
11173140
18.

Adenovirus-mediated antisense ATM gene transfer sensitizes prostate cancer cells to radiation.

Fan Z, Chakravarty P, Alfieri A, Pandita TK, Vikram B, Guha C.

Cancer Gene Ther. 2000 Oct;7(10):1307-14.

19.

A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats.

Sauter BV, Parashar B, Chowdhury NR, Kadakol A, Ilan Y, Singh H, Milano J, Strayer DS, Chowdhury JR.

Gastroenterology. 2000 Nov;119(5):1348-57.

PMID:
11054394
20.

Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days.

Ramirez P, Chavez R, Majado M, Munitiz V, Muñoz A, Hernandez Q, Palenciano CG, Pino-Chavez G, Loba M, Minguela A, Yelamos J, Gago MR, Vizcaino AS, Asensi H, Cayuela MG, Segura B, Marin F, Rubio A, Fuente T, Robles R, Bueno FS, Sansano T, Acosta F, Rodriguez JM, Navarro F, Cabezuelo J, Cozzi E, White DJ, Calne RY, Parrilla P.

Transplantation. 2000 Oct 15;70(7):989-98.

PMID:
11045632

Supplemental Content

Support Center